Gene: DOT1L
Official Full Name: DOT1 like histone lysine methyltransferaseprovided by HGNC
Gene Summary: The protein encoded by this gene is a histone methyltransferase that methylates lysine-79 of histone H3. It is inactive against free core histones, but shows significant histone methyltransferase activity against nucleosomes. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09482 | DOT1L Knockout cell line (HeLa) | Human | DOT1L | 1:3~1:6 | Negative | Online Inquiry |
KO09483 | DOT1L Knockout cell line (HCT 116) | Human | DOT1L | 1:2~1:4 | Negative | Online Inquiry |
KO09484 | DOT1L Knockout cell line (HEK293) | Human | DOT1L | 1:3~1:6 | Negative | Online Inquiry |
KO09485 | DOT1L Knockout cell line (A549) | Human | DOT1L | 1:3~1:4 | Negative | Online Inquiry |
DOT1L Gene Knockout Cell Lines are meticulously engineered cellular models designed for the specific interruption of the DOT1L gene function, a critical player in epigenetic regulation through the methylation of histone H3 at lysine 79. By employing CRISPR/Cas9 technology, these cell lines eliminate the expression of DOT1L, enabling researchers to investigate its role in various cellular processes, particularly in relation to gene expression regulation, cellular differentiation, and oncogenesis.
The key function of DOT1L Gene Knockout Cell Lines lies in their ability to facilitate targeted studies into the molecular mechanisms that underpin diseases associated with dysregulated histone methylation, such as cancer and other epigenetic disorders. By understanding the impact of DOT1L depletion on gene expression profiles, investigators can elucidate pathways and networks potentially involved in tumorigenesis and other pathological conditions.
Scientifically, the importance of these knockout cell lines extends into both research and clinical settings, where they serve as invaluable tools for drug discovery, biomarker identification, and the development of targeted therapies. Researchers can evaluate the effects of therapeutic agents under conditions of DOT1L absence, allowing for insights into potential treatment strategies for DOT1L-linked malignancies.
What sets DOT1L Gene Knockout Cell Lines apart from alternative models is their precision and reliability in simulating the absence of DOT1L, ensuring reproducibility in experimental conditions. With the versatility to be used across various cell types, these lines offer a powerful platform for a wide range of biological inquiries.
For researchers and clinicians alike, the availability of DOT1L Gene Knockout Cell Lines presents an unmatched opportunity to advance our understanding of gene regulation and to potentially pioneer innovative therapeutic approaches. Our company specializes in providing high-quality, specially tailored biological products, ensuring that our clients have access to state-of-the-art resources for their scientific endeavors. Through dedicated expertise in genetic engineering, we are committed to supporting the frontiers of biomedical research with cutting-edge tools like the DOT1L Gene Knockout Cell Lines.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.